speb/financial-data huggingface dataset:
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Ordinary Shares Number: 1002089000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Other Equity Interest: 6500000.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Other Income Expense: 0.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 4291200000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 64213900000.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 5716100000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Share Issued: 1002089000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Stockholders Equity: 165985100000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Tangible Book Value: 165985100000.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 207900000.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.04
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Total Assets: 4511009500000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Total Capitalization: 165985100000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Total Equity Gross Minority Interest: 165985100000.00
SBILIFE.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 182887800000.00
SBILIFE.NS balance_sheet (quarterly, 2024-12-31) — Total Liabilities Net Minority Interest: 4345024400000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — +Total Revenue: 1154124500000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 230623500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 12576300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 12576300000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 7880200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 7880200000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -5011600000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -5011600000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 1556600000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1556600000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 303038300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 303038300000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 1001823654.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 1001859606.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Basic EPS: 24.09
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 8.12
SBILIFE.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 65957700000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 4086000000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 4086000000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1061900000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 10021400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 10021400000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 17835800000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 17835800000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 19562700000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 19562700000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -2706000000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Cash Flowsfromusedin Operating Activities Direct: 255466500000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 35429900000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Classesof Cash Payments: -598941900000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Classesof Cash Receiptsfrom Operating Activities: 854408400000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Common Stock: 10021400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 10021400000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Common Stock Dividend Paid: -2706000000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 169853500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 169853500000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 557900000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 100200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 100200000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 837500000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 837500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Derivative Product Liabilities: 10488500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 10488500000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 1002657711.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 1003094945.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Diluted EPS: 24.07
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 8.11
SBILIFE.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — EBIT: 25061100000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 0.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — End Cash Position: 101387600000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Financial Assets: 11471800000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets: 11471800000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -2148100000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 254404600000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 2338000000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Goodwill: 0.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 147400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 147400000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 10767500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 10767500000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Interest Expense: 114400000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 114400000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Interest Income: 188258200000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 169853500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 169853500000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -217888500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Investment Properties: 315029900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Investment Properties: 315029900000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 1655286700000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 1655286700000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Investments And Advances: 1657013600000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 1657013600000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Investmentsin Subsidiariesat Cost: 0.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Subsidiariesat Cost: 0.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 557900000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 1762500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 1762500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 0.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 3814200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 3814200000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 4816300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 4816300000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 557900000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income Extraordinary: 0.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income Extraordinary: 0.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Interest Income: -114400000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -409200100000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 0.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -114400000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -2706000000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: 193297000000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Net PPE: 5755900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 5755900000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1057300000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Net Policyholder Benefits And Claims: 491990200000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Net Policyholder Benefits And Claims: 130847400000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 169706100000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 169706100000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 0.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Normalized Income: 24133000000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 8135100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Operating Revenue: 1154124500000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 230623500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 1002135083.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 1002135083.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -100000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Other Cash Paymentsfrom Operating Activities: -42160500000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Other Cash Receiptsfrom Operating Activities: 13000000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 45600000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 45600000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Other Income Expense: 0.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Other Income Expense: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 147400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 147400000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 2372800000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: -276500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Other Payable: 19661800000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 19661800000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Other Properties: 2500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 2500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 41510200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 41510200000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 1726900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 1726900000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Payables: 36890000000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Payables: 36890000000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 1244000000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1244000000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Pretax Income: 24946700000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 8406100000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -2384728500000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1061900000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Receivables Adjustments Allowances: -400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -400000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 837500000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 1130100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 1130100000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 156305700000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 156305700000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 1975528400000.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 4600000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 3449900000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 5787900000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Share Issued: 1002135083.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 1002135083.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 0.00
SBILIFE.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: 0.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 169853500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 169853500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 169706100000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 169706100000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Tax Provision: 813700000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 271000000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.03
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.03
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 2976200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 2976200000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Total Assets: 4570954300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 4570954300000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 169853500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 169853500000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 169853500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 169853500000.00
SBILIFE.NS income_statement (annual, 2025-03-31) — Total Expenses: 1130126800000.00
SBILIFE.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 222217600000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4401100800000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4401100800000.00
SBILIFE.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 4651900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 4651900000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 390129400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 2083111200000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 1002310287.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 5.93
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Capital Stock: 10023500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 24400300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 24400300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Common Stock: 10023500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 178383400000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 1002310287.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 5.93
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 5943700000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Invested Capital: 178383400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 2083111200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 2083111200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Long Term Provisions: 4252600000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income: 5943700000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 5943700000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 5943700000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income Extraordinary: 0.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 5943700000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 5943700000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 5943700000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Net PPE: 6186000000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Net Policyholder Benefits And Claims: 105383300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 178383400000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 5943700000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 390129400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 1002351320.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: 1800000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Other Income Expense: 0.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 5885300000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 6109500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Share Issued: 1002351320.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 178383400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 178383400000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 165800000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.03
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Total Assets: 4850802200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 178383400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 178383400000.00
SBILIFE.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 384019900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 4672418800000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 461102500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Available For Sale Securities: 2275393900000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 1003026087.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 5.75
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Capital Stock: 10028300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19143600000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 19143600000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Common Stock: 10028300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 190195900000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 1003026087.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 5.75
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5767400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Invested Capital: 190195900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 2275393900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2275393900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Long Term Provisions: 5338700000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income: 5767400000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5767400000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5767400000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income Extraordinary: 0.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5767400000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5767400000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5767400000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Net PPE: 6371100000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Net Policyholder Benefits And Claims: 153697500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 190195900000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 5767400000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 461102500000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 1002829838.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: 1300000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Other Income Expense: 0.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1775000000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 5975300000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Share Issued: 1002829838.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 190195900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 190195900000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 207900000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.03
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Total Assets: 5206709000000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 190195900000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 190195900000.00
SBILIFE.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 455127200000.00
SBILIFE.NS balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5016513100000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — +Total Revenue: 1104781600000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 40949200000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 13576000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 13576000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 13224700000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 13224700000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -5611100000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -5611100000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 2470000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 2470000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 383382100000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 383382100000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 1002549634.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 1003291771.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Basic EPS: 24.64
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 8.02
SBILIFE.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 101387600000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 4386300000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 4386300000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1850000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 10030900000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 10030900000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 31875600000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 31875600000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 37401800000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 37401800000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -2708000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Cash Flowsfromusedin Operating Activities Direct: 345226700000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -9741200000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Classesof Cash Payments: -675975000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Classesof Cash Receiptsfrom Operating Activities: 1021201700000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Common Stock: 10030900000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 10030900000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Common Stock Dividend Paid: -2708000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 190860000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 190860000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 920000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 409700000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 409700000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 1154200000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 1154200000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Derivative Product Liabilities: 22336100000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Derivative Product Liabilities: 22336100000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 1003272179.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 1003291771.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Diluted EPS: 24.62
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 8.02
SBILIFE.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — EBIT: 25485900000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 0.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — End Cash Position: 91646400000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Financial Assets: 710900000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Financial Assets: 710900000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -1788000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 343376700000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 2628300000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Goodwill: 0.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 390300000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 390300000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 12097500000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 12097500000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Interest Expense: 111900000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 111900000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Interest Income: 203845600000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 190860000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 190860000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -353179900000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Investment Properties: 338199400000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Investment Properties: 338199400000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 1901687800000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1901687800000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Investments And Advances: 1907214000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 1907214000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Investmentsin Subsidiariesat Cost: 0.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Investmentsin Subsidiariesat Cost: 0.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 920000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Issuance Of Debt: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Land And Improvements: 1762500000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 1762500000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Long Term Equity Investment: 0.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 4844900000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 4844900000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 5539000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 5539000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 920000000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income Extraordinary: 0.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income Extraordinary: 0.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Interest Income: -111900000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -513139400000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -111900000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -2708000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: 163038400000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Net PPE: 6486400000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 6486400000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -1845700000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Net Policyholder Benefits And Claims: 546123700000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Net Policyholder Benefits And Claims: 172159700000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 190469700000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 190469700000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 0.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Normalized Income: 24703000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 8046400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Operating Revenue: 1104781600000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 40949200000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 1003092121.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1003092121.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Other Cash Paymentsfrom Operating Activities: -51322200000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 66000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 66000000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Other Income Expense: 0.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Other Income Expense: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 390300000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 390300000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: -626400000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: -1544700000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Other Payable: 25398400000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Other Payable: 25398400000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 50743600000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 50743600000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 5526200000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 5526200000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Payables: 41212800000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Payables: 41212800000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Prepaid Assets: 1893700000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1893700000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Pretax Income: 25374000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 8157800000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -2955053000000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -1850000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Receivables Adjustments Allowances: -2000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Receivables Adjustments Allowances: -2000000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 1154200000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Rent And Landing Fees: 1357900000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Rent Expense Supplemental: 1357900000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Retained Earnings: 178300600000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 178300600000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 2441913600000.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 4300000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Selling And Marketing Expense: 4259700000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 6888000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Share Issued: 1003092121.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 1003092121.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Short Term Debt Issuance: 0.00
SBILIFE.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: 0.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 190860000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 190860000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 190469700000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 190469700000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Tax Provision: 671000000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 111400000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.03
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.01
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 1538700000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 1538700000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Total Assets: 5000459100000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 5000459100000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 190860000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 190860000000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 190860000000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 190860000000.00
SBILIFE.NS income_statement (annual, 2026-03-31) — Total Expenses: 1079407400000.00
SBILIFE.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 32791500000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 4809599100000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4809599100000.00
SBILIFE.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 2238400000.00
SBILIFE.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 2238400000.00
SBIN.NS cash_flow (annual, 2022-03-31) — Common Stock Payments: 0.00
SBIN.NS cash_flow (annual, 2022-03-31) — Dividends Received Cfi: 31950000.00
SBIN.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -33052601000.00
SBIN.NS cash_flow (annual, 2022-03-31) — Repurchase Of Capital Stock: 0.00
SBIN.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 2543431000.00
SBIN.NS income_statement (annual, 2023-03-31) — +Operating Expense: 1861696085000.00
SBIN.NS income_statement (annual, 2023-03-31) — +Total Revenue: 2703369068000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 274950255000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -366053269000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 791154768000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 797507703000.00
SBIN.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 8924611707.00
SBIN.NS income_statement (annual, 2023-03-31) — Basic EPS: 62.35
SBIN.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3989051217000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -40436315000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 8924612000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 5369031044000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 5369031044000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -63367216000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 113481426000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 216284177000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -605317228000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 757137397000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1753593949000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -836682666000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Common Stock: 8924612000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -63367216000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 3589313181000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 64000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3835664000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Depreciation: 36955986000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 36955986000.00
SBIN.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 36955986000.00
SBIN.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 36955986000.00
SBIN.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 8924611707.00
SBIN.NS income_statement (annual, 2023-03-31) — Diluted EPS: 62.35
SBIN.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 556481728000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Dividends Received Cfi: 26625000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Effect Of Exchange Rate Changes: 30750546000.00
SBIN.NS cash_flow (annual, 2023-03-31) — End Cash Position: 3183119097000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 63863820000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Fixed Assets Revaluation Reserve: 639825804000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -900573111000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 49199473000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of Business: 0.00
SBIN.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 290316000.00
SBIN.NS income_statement (annual, 2023-03-31) — Gain On Sale Of Security: 2354761000.00
SBIN.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 8012637000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Goodwill: 15383627000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 15383627000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 810127079000.00
SBIN.NS income_statement (annual, 2023-03-31) — Insurance And Claims: 53406901000.00
SBIN.NS income_statement (annual, 2023-03-31) — Interest Expense: 1899808167000.00
SBIN.NS income_statement (annual, 2023-03-31) — Interest Income: 3508445801000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -63246256000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 8810239487000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -40409690000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 18969186428000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Investments And Advances: 19131078564000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Investmentsin Associatesat Cost: 1760239000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Investmentsin Subsidiariesat Cost: 160131897000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 64000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 195330926000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 5220926306000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 195330926000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -21250000000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 161892136000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Minority Interest: 128366194000.00
SBIN.NS income_statement (annual, 2023-03-31) — Minority Interests: -21017092000.00
SBIN.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
SBIN.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 64000.00
SBIN.NS balance_sheet (annual, 2023-03-31) — Net Debt: 2028400400000.00
SBIN.NS income_statement (annual, 2023-03-31) — Net Income: 556481728000.00
SBIN.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 556481728000.00